期刊文献+

阿司匹林联合低分子肝素治疗习惯性流产的疗效观察 被引量:24

下载PDF
导出
摘要 目的观察阿司匹林联合低分子肝素治疗习惯性流产的疗效。方法随机将91例不明原因习惯性流产患者分为单药治疗组(30例,单用阿司匹林治疗)、联合治疗组(阿司匹林联合低分子肝素联合治疗31例)和对照组(淀粉片治疗,30例),用药时间为从宫内妊娠确诊开始给药,直至临产或者发生流产、早产。比较3组活产率、流产率、产科并发症以及母婴不良结局发生率。结果 3组妊娠率差异无统计学意义(>0.05),3组活产率差异有统计学意义(<0.05);3组绝对活产率差异有统计学意义(<0.05)。3组均无新生儿畸形发生,均无HELLP综合征/胎盘早剥发生。联合治疗组流产率、瘀斑发生率均低于单药治疗组和对照组,差异均有统计学意义(均<0.05);联合治疗组分娩孕周长于单药治疗组和对照组,差异均有统计学意义(均<0.05)。3组子痫前期发生率、流产孕周、分娩出血量、血小板减少发生率、胃肠道反应发生率差异无统计学意义(均>0.05)。结论阿司匹林联合低分子肝素治疗能有效改善不明原因习惯性流产患者的妊娠结局。
出处 《现代实用医学》 2011年第5期563-565,共3页 Modern Practical Medicine
  • 相关文献

参考文献7

  • 1Rai R,Regan L.Recurrent miscarriage[J].Lancet,2006,36(8):601-611.
  • 2Dolitzky M,Inbal A,Segal Y,et al.A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages[J].Fertil Steril,2006,8(6):362-366.
  • 3Kaandorp S,Di Nisio M,Goddijn M,et al.Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome[J].Cochrane Database Syst Rev2009,21(1):CD004734.
  • 4Lockshin MD.Pregnancy loss in the antiphospholipid syndrome[J].Thromb Haemost,1999,8(2):641-648.
  • 5郭永,马丽,邓艳艳.小剂量阿司匹林在治疗习惯性流产中的作用[J].中国医疗前沿,2008,3(13). 被引量:10
  • 6刘宗花,王谢桐.低分子肝素治疗自身免疫型复发性流产的作用机制及安全性[J].山东医药,2007,47(20):114-115. 被引量:42
  • 7Girardi G,Redecha P,Salmon J,et al.A potential mechanism for therapeutics efficacy ofheparin in antiphospholipid antibodies induced pregnancy loss inhibition of complement[J].NatMed,2004,10(5):1222-1226.

二级参考文献18

  • 1胡颖,卢兴国.肾病综合征患者纤溶酶原激活物及其抑制物的变化及低分子肝素干预研究[J].中国实用内科杂志,2005,25(1):74-75. 被引量:11
  • 2Borsig L. Selectins facilitate carcinoma metastasis and heparin can prevent them [ J ]. News Physiol Sci,2004,19 (7) : 16-21.
  • 3Derksen RH, Khamashta MA, Branch DW. Management of the obstetric antiphospholipid syndrome [ J ]. Arthritis Rheum, 2004,50 ( 9 ) : 1028-1039.
  • 4Girardi G, Redecha P, Salmon J, et al. A potential mechanism for therapeutics efficacy of heparin in antiphospholipid antibodies induced pregnancy loss inhibition of complement[ J ]. Nat Med ,2004,10( 5 ) : 1222-1226.
  • 5Chamley LW. Antiphospholipid antibodies: biological basis and prospects for treatment [ J ] . Reprod lmmunol, 2002, 57 ( 12 ) : 185-202.
  • 6Girardi G. Heparin treatment in pregnancy loss : potential therapeutic benefits beyond anticoagulation[ J]. Immunology,2005,6(6) :45-51.
  • 7Rodney D, Franklin H, William, et al. Effects of unfractionated and low molecular weight heparin on antiphospholipid antibody binding in vitro[ J ] . Division Endocrinology and Immunology, 2003,101 ( 3 ) : 455 -462.
  • 8Bose P, Black S, Kadyrov M, et al. Heparin and aspirin attenuate placental apoptosis in vitro: Implications for early pregnancy failure [ J]. AM J Obstet and Gynecol,2005,19(2) :23-30.
  • 9Hamatani T, Daikoku T, Wang H, et al. Global gene expression analysis identifies molecular pathways distinguishing blastocyst dormancy and activation[ J]. Acad Sc1,2004,101 (3) : 10326-10331.
  • 10Tzafettas J, Petropoulos P, Psarra A, et al. Early antiplatetelet and antlthrombotic therapy in patients with a history of recurrent miscarriages of known and unknown aeriology[ J]. Eur J Obstet Gyneco1,2005, 120( 1 ) :22-26.

共引文献46

同被引文献110

引证文献24

二级引证文献290

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部